Dapagliflozin Dimer Impurity
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

Dapagliflozin Dimer Impurity

● In Stock

Catalogue No.:VE008507
CAS No.:N/A
Mol. Formula:C42H48Cl2O12
Mol. Weight:815.7 g/mol

Additional information on Dapagliflozin Dimer Impurity

Parent drug

Dapagliflozin

IUPAC Name

(2S, 3R, 4S, 5S, 6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-2-(((2R, 3S, 4R, 5R, 6R)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)-3, 4, 5-trihydroxytetrahydro-2H-pyran-2-yl)methoxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3, 4, 5-triol

Synonyms

N/A

Description

Dapagliflozin Dimer Impurity is an impurity present in Dapagliflozin, Dapagliflozin inhibits the sodium-glucose cotransporter 2(SGLT2) which is primarily located in the proximal tubule of the nephron1, SGLT2 facilitates 90% of glucose resorption in the kidneys and so its inhibition allows for glucose to be excreted in the urine.

References

Anderson, S. L. (2014). Dapagliflozin efficacy and safety: a perspective review. Therapeutic Advances in Drug Safety, 5(6), 242–254. https://doi.org/10.1177/2042098614551938 ‌

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url